Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	681.49	593.24	498.99	437.77	349.85	322.36
Other Revenue	42.06	51.16	-	-	-	-
Revenue	723.55	644.4	498.99	437.77	349.85	322.36
Revenue Growth (YoY)	20.33%	29.14%	13.98%	25.13%	8.53%	9.40%
Cost of Revenue	340.2	290.57	250.13	238.03	206.51	190.43
Gross Profit	383.35	353.82	248.86	199.74	143.34	131.92
Selling, General & Admin	92.9	80.39	66.59	67.12	62.86	63.11
Research & Development	76.19	73.74	74.77	60.93	67.23	68.85
Operating Expenses	169.09	154.13	141.36	128.05	130.09	131.96
Operating Income	214.26	199.69	107.5	71.69	13.25	-0.04
Interest Expense	-37.67	-27.16	-1.85	-0.89	-0.37	-0.12
Interest & Investment Income	10.62	5.46	1.32	0.6	0.64	1
Earnings From Equity Investments	-1.08	-1.98	-1.18	-0.21	-	-
Other Non Operating Income (Expenses)	-0.06	-3.93	3.67	13.54	6.22	-0.51
EBT Excluding Unusual Items	186.07	172.08	109.46	84.73	19.74	0.33
Asset Writedown	-	-2.7	-	-	-	-
Legal Settlements	-	-	5.4	1	-12.8	59.9
Other Unusual Items	-	-	-	-1.8	-2.3	-
Pretax Income	186.07	169.38	114.86	83.93	4.64	60.23
Income Tax Expense	28.35	31.83	23.48	20.63	3.54	13.72
Earnings From Continuing Operations	157.72	137.55	91.39	63.3	1.1	46.51
Minority Interest in Earnings	-	-	-	-1.19	0.31	2.43
Net Income	157.72	137.55	91.39	62.12	1.4	48.94
Net Income to Common	157.72	137.55	91.39	62.12	1.4	48.94
Net Income Growth	16.58%	50.51%	47.12%	4327.37%	-97.13%	-
Shares Outstanding (Basic)	48	48	49	48	47	47
Shares Outstanding (Diluted)	52	53	52	50	49	50
Shares Change (YoY)	-0.37%	1.09%	5.31%	1.34%	-1.57%	7.57%
EPS (Basic)	3.26	2.85	1.88	1.30	0.03	1.04
EPS (Diluted)	3.01	2.60	1.74	1.25	0.03	0.98
EPS Growth	17.38%	49.43%	39.20%	4090.97%	-96.96%	-
Free Cash Flow	170.15	145.34	65.15	70.54	23.41	0.21
Free Cash Flow Per Share	3.24	2.74	1.24	1.42	0.48	0.00
Gross Margin	52.98%	54.91%	49.87%	45.63%	40.97%	40.92%
Operating Margin	29.61%	30.99%	21.54%	16.38%	3.79%	-0.01%
Profit Margin	21.80%	21.34%	18.31%	14.19%	0.40%	15.18%
Free Cash Flow Margin	23.52%	22.55%	13.06%	16.11%	6.69%	0.06%
EBITDA	266.61	237.72	132.27	94.95	34.78	18.07
EBITDA Margin	36.85%	36.89%	26.51%	21.69%	9.94%	5.61%
D&A For EBITDA	52.36	38.04	24.77	23.27	21.53	18.11
EBIT	214.26	199.69	107.5	71.69	13.25	-0.04
EBIT Margin	29.61%	30.99%	21.54%	16.38%	3.79%	-0.01%
Effective Tax Rate	15.23%	18.79%	20.44%	24.58%	76.34%	22.79%
Revenue as Reported	723.55	644.4	498.99	437.77	-	-
Advertising Expenses	-	10.4	8.7	8.1	5.8	4.3

Source: S&P Capital IQ. Standard template. Financial Sources.